Published in Prostaglandins Leukot Essent Fatty Acids on March 01, 2003
Statement on the nomenclature of human C4 allotypes. Immunobiology (1983) 2.66
Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood (1996) 1.78
Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol (1999) 1.76
The pathophysiology of tremor. Muscle Nerve (2001) 1.76
Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations. Lancet (1993) 1.76
Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet (1993) 1.68
Autoimmune human T lymphocytes specific for acetylcholine receptor. Nature (1984) 1.63
Trends in amputations in people with hospital admissions for peripheral arterial disease in Germany. Vasa (2011) 1.48
Detection of chromium allergy by cellular in vitro methods. Clin Exp Allergy (2008) 1.47
The extent of traumatic damage determines a graded depression of the endotoxin responsiveness of peripheral blood mononuclear cells from patients with blunt injuries. Crit Care Med (1999) 1.46
Klippel-Trenaunay syndrome and pregnancy. Int Angiol (2003) 1.45
Trends in lower extremity surgical and endovascular revascularization in Germany. Vasa (2011) 1.41
Monitoring of soluble HLA class I size variants after liver transplantation. Hum Immunol (1999) 1.40
Complement-mediated phagocytosis of Pseudomonas aeruginosa. J Lab Clin Med (1978) 1.37
HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Ann Surg (1999) 1.31
Biological variability in the structures of diphosphoinositol polyphosphates in Dictyostelium discoideum and mammalian cells. Biochem J (1997) 1.27
The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia. Leukemia (2010) 1.25
HLA-D typing in multiple sclerosis: Israelis tested with European homozygous typing cells. Tissue Antigens (1982) 1.19
Determinants of physiologic tremor in a large normal population. Clin Neurophysiol (2000) 1.18
Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens (2001) 1.15
A computational algorithm for minimizing total variation in image restoration. IEEE Trans Image Process (1996) 1.12
Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders. Clin Immunol Immunopathol (1992) 1.12
Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens (1999) 1.11
T-Cell response to woodchuck hepatitis virus (WHV) antigens during acute self-limited WHV infection and convalescence and after viral challenge. J Virol (1998) 1.10
The pathophysiology of parkinsonian tremor: a review. J Neurol (2000) 1.10
Impact of localized radiotherapy on blood immune cells counts and function in humans. Radiother Oncol (1999) 1.10
Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. Cancer (2001) 1.06
Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy. Exp Clin Endocrinol Diabetes (2000) 1.06
Joint report of the Second International Workshop on Canine Immunogenetics. Transplant Proc (1976) 1.05
Multiple oscillators are causing parkinsonian and essential tremor. Mov Disord (2000) 1.05
Surface markers and mitogen response of cells harvested from cutaneous infiltrates in mycosis fungoides and Sézary's syndrome. J Invest Dermatol (1978) 1.01
Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest (1998) 1.00
Catecholamines increase lymphocyte beta 2-adrenergic receptors via a beta 2-adrenergic, spleen-dependent process. Am J Physiol (1990) 0.99
Prevalence of latent tuberculosis infection in German radiologists. J Hosp Infect (2008) 0.99
Vitamin B6 deficiency in uremia and its implications for the depression of immune responses. Kidney Int (1974) 0.98
The G protein beta3 subunit 825T allele is a genetic marker for enhanced T cell response. FEBS Lett (2001) 0.97
14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project. Tissue Antigens (2007) 0.95
Antiphosphatidylserine antibodies are elevated in normal tension glaucoma. Clin Exp Immunol (2001) 0.95
Love for hire: the regulation of the wet-nursing business in eighteenth-century Hamburg. J Fam Hist (1981) 0.94
A new restriction fragment length polymorphism of the human TNF-B gene detected by AspHI digest. Eur J Immunogenet (1992) 0.92
Soluble HLA levels in early pregnancy after in vitro fertilization. Hum Immunol (2000) 0.92
Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma. Lancet (2000) 0.92
Detection of major and minor sex pheromone components by the male codling moth Cydia pomonella (Lepidoptera: Tortricidae). J Insect Physiol (1997) 0.92
Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay. Blut (1989) 0.91
Linkage group HL-A-MLC-BF (properdin factor B). The site of the Bf locus at the immunogenetic linkage group on chromosome 6. Humangenetik (1975) 0.91
Lack of linkage between gene(s) controlling the synthesis of the seventh component of complement and the HLA region on chromosome No. 6 in man. Hum Genet (1976) 0.91
Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-gamma). Clin Exp Immunol (1991) 0.90
Fatal Hodgkin and non-Hodgkin lymphoma associated with persistent Epstein-Barr virus in four brothers. Ann Intern Med (1988) 0.89
Soluble HLA-G is an independent factor for the prediction of pregnancy outcome after ART: a German multi-centre study. Hum Reprod (2010) 0.89
[Infection following intramedullary nailing]. Chirurg (1973) 0.88
Differential activation of mitogen-activated protein kinases in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol (2000) 0.88
Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man. Clin Immunol Immunopathol (1994) 0.87
Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma. Inflamm Res (2007) 0.87
Assessment of peripheral blood mononuclear cell proliferation by [2-3H]adenine uptake in the woodchuck model. Clin Immunol Immunopathol (1996) 0.87
Enumeration of T, B and natural killer peripheral blood cells of patients with multiple sclerosis and controls. Eur Neurol (1992) 0.87
Immunogenetic marrow donor search for 1012 patients: a retrospective analysis of strategies, outcome and costs. Bone Marrow Transplant (1994) 0.87
Factors contributing to the success of folic acid public health campaigns. J Public Health (Oxf) (2011) 0.86
Cellular and humoral immune response to a third generation hepatitis B vaccine. J Viral Hepat (2007) 0.86
A typical MLC reactions in HL-A-typed related and unrelated pairs. Transplant Proc (1973) 0.86
Detection of mutations in glycoprotein hormone receptors. Methods (2000) 0.86
C4 allotyping by prolonged gel electrophoresis and immunoblotting using monoclonal and polyclonal antibodies. Complement Inflamm (1990) 0.85
Specificity and functional characteristics of anti-HLA-A mAbs LGIII-147.4.1 and LGIII-220.6.2. Tissue Antigens (2003) 0.85
HLA-DP antibodies in patients awaiting renal transplantation. Transpl Int (1995) 0.84
Population data on two new HLA-D determinants, EI and RE. Scand J Immunol (1977) 0.84
Placental abruption is associated with decreased maternal plasma levels of soluble HLA-G. J Clin Immunol (2003) 0.84
SD vs. LD antigens as targets for lymphocyte-mediated cytotoxicity: study of a family presenting a recombination event within the MHR. Transplant Proc (1973) 0.84
Quantification and identification of soluble HLA-G isoforms. Tissue Antigens (2007) 0.84
Multimarker classification of acute lymphoblastic leukemia: evidence for further T subgroups and evaluation of their clinical significance. Blood (1980) 0.84
[Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters]. Dtsch Med Wochenschr (1983) 0.84
Linkage disequilibrium between HL-A7 and the MLC specificity Pi. Transplant Proc (1973) 0.84
Immunosuppression with FK506 increases bone induction in demineralized isogeneic and xenogeneic bone matrix in the rat. J Bone Miner Res (2000) 0.83
Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on beta 2-microglobulin-associated and beta 2-microglobulin-free HLA class I heavy chains. J Immunol (2000) 0.83
Soluble HLA class I concentrations and GVHD after allogeneic marrow transplantation. Transplantation (1989) 0.83
Determination of peripheral blood mononuclear cell responses to mitogens and woodchuck hepatitis virus core antigen in woodchucks by 5-bromo-2'-deoxyuridine or 2[3H]adenine incorporation. Arch Virol (1997) 0.83
ELISpot: a new tool for the detection of nickel sensitization. Clin Exp Allergy (2003) 0.83
HLA-DB3: population distribution and family studies of a new HLA-D antigen associated with HLA-D antigen associated with HLA-DR4 in Caucasoids. Tissue Antigens (1983) 0.83
Hypokalemic rhabdomyolysis with myoglobinuria due to licorice ingestion and diuretic treatment. Klin Wochenschr (1983) 0.83
Sequence-based typing reveals a novel DLA-88 allele, DLA-88*04501, in a beagle family. Tissue Antigens (2006) 0.83
Immune response to perforated and partially demineralized bone allografts. J Orthop Sci (2001) 0.82
Significant association of acute lymphoblastic leukemia with HLA-Cw7. Genet Epidemiol (1988) 0.82
Lung effects after total body irradiation of mice and bone marrow transplant patients: comparison of experimental and preliminary clinical data. Recent Results Cancer Res (1993) 0.82
[Clinical course and prognostic significance of immunological and functional parameters after severe trauma]. Unfallchirurg (2004) 0.82
Quantitation of soluble HLA class II molecules by an enzyme-linked immunosorbent assay. Vox Sang (1991) 0.82
Characterization of transfusion-induced suppressor cells in prospective kidney allograft recipients. Transplant Proc (1982) 0.82
Reduced B cell HLA-DR expression and natural killer cell counts in patients prone to sepsis after injury. Eur J Surg (1999) 0.82
Follow-up of treated adult celiac disease: clinical and morphological studies. Hepatogastroenterology (1982) 0.81
[Meniere disease as an autosome dominant hereditary disease]. Laryngorhinootologie (1995) 0.81
Expression and function of Toll-like receptor 9 in severely injured patients prone to sepsis. Clin Exp Immunol (2006) 0.81
Population genetics of the MLC response: typing for MLC determinants using homozygous and heterozygous reference cells. Transplant Proc (1973) 0.81